Multidrug-Resistant Salmonella enterica Serovar Infantis, Israel
Ohad Gal-Mor , Lea Valinsky, Miriam Weinberger, Sara Guy, Joseph Jaffe, Yosef Ilan Schorr, Abraham Raisfeld, Vered Agmon, and Israel Nissan
Author affiliations: Sheba Medical Center, Tel-Hashomer, Israel (O. Gal-Mor); Ministry of Health Laboratories, Jerusalem, Israel (L. Valinsky, S. Guy, J. Jaffe, Y.I. Schorr, A. Raisfeld, V. Agmon, I. Nissan); Assaf Harofeh Medical Center, Zerifin, Israel (M. Weinberger)
Figure 2. Pulsed-field gel electrophoresis (PFGE) patterns of Salmonella enterica serovar Infantis isolates from clinical, food, and poultry sources isolated in Israel, 1970–2009, showing a high degree of clonality. Isolate number, year of isolation, and source are indicated. Bracket indicates I1 pulsotype pattern. Macrodigestion performed using XbaI restriction enzyme and genetic similarity (in %) was based on dice coefficients. PFGE was conducted according to the standardized Salmonella protocol Centers for Disease Prevention and Control PulseNet as described (4) by using S. enterica ser. Braenderup H9812 strain as a molecular size standard. Because of space limitations, only 34/58 pulsotype I1 clones are shown. A complete list is provided in the Appendix Table.
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.